The global flow cytometry market was valued at USD 5.29 billion in 2024, with advancements in artificial intelligence (AI)-)-enabled automated systems acting as a key driver. This technology has significantly improved precision and efficiency in cell analysis, making flow cytometry an essential tool in various applications, including immunology, hematology, and cancer diagnostics. With...